Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells

Biomaterials

Volumn 35, Issue 25, 2014, Pages 6998-7007

  Li, Wan Ming ^a   Bing, Tao ^b   Wei, Jia Yi ^a   Chen, Zhe Zhou ^a   Shangguan, Di Hua ^b   Fang, Jin ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF CHEMISTRY   (China)

Author keywords

Aptamer; Cell SELEX; Drug delivery; Metastatic colorectal cancer; Molecular imaging; Quantum dots

Indexed keywords

CELL CULTURE; CELL MEMBRANES; DRUG DELIVERY; MOLECULAR IMAGING; PATHOLOGY; SEMICONDUCTOR QUANTUM DOTS; TISSUE;

APTAMERS; CELL-SELEX; COLORECTAL CANCER; COLORECTAL CANCER CELL; COLORECTAL CANCERS (CRC); METASTATIC CANCER CELLS; MOLECULAR TARGETS; TARGETED IMAGING;

DISEASES;

APTAMER; DOXORUBICIN; QUANTUM DOT; MOLECULAR PROBE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL SELECTION; CELL SURFACE; COLORECTAL CANCER CELL LINE; COMBINATORIAL CHEMISTRY; CYTOTOXICITY; DNA LIBRARY; DNA STRUCTURE; DRUG DELIVERY SYSTEM; EMBRYO; ENDOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG METASTASIS; METASTATIC COLORECTAL CANCER; MOLECULAR IMAGING; MOLECULAR PROBE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; TARGET CELL; 3T3 CELL LINE; ANIMAL; CHEMISTRY; CHO CELL LINE; COLORECTAL TUMOR; CRICETULUS; DIAGNOSTIC IMAGING; METABOLISM; NUDE MOUSE; PROCEDURES; TUMOR CELL LINE;

MURINAE;

ANIMALS; APTAMERS, NUCLEOTIDE; CELL LINE, TUMOR; CHO CELLS; COLORECTAL NEOPLASMS; CRICETULUS; DIAGNOSTIC IMAGING; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MICE; MICE, NUDE; MOLECULAR PROBES; NIH 3T3 CELLS; QUANTUM DOTS; SELEX APTAMER TECHNIQUE;

EID: 84902118837     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.04.112     Document Type: Article

References (37)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics. CA Cancer J Clin 2013, 2013(63):11-30.
2. Shah S.A., Haddad R., Al-Sukhni W., Kim R.D., Greig P.D., Grant D.R., et al. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. JAm Coll Surg 2006, 202:468-475.
3. Bird N.C., Mangnall D., Majeed A.W. Biology of colorectal liver metastases: a review. JSurg Oncol 2006, 94:68-80.
4. Ellington A.D., Szostak J.W. Invitro selection of RNA molecules that bind specific ligands. Nature 1990, 346:818-822.
5. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249:505-510.
6. Berezovski M.V., Lechmann M., Musheev M.U., Mak T.W., Krylov S.N. Aptamer-facilitated biomarker discovery (AptaBiD). JAm Chem Soc 2008, 130:9137-9143.
7. Gong P., Shi B., Zheng M., Wang B., Zhang P., Hu D., et al. PEI protected aptamer molecular probes for contrast-enhanced invivo cancer imaging. Biomaterials 2012, 33:7810-7817.
8. Wang C.H., Kang S.T., Lee Y.H., Luo Y.L., Huang Y.F., Yeh C.K. Aptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosis. Biomaterials 2012, 33:1939-1947.
9. Fang X., Tan W. Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach. Acc Chem Res 2010, 43:48-57.
10. Keefe A.D., Pai S., Ellington A. Aptamers as therapeutics. Nat Rev Drug Discov 2010, 9:537-550.
11. Khati M. The future of aptamers in medicine. JClin Pathol 2010, 63:480-487.
12. Sefah K., Shangguan D., Xiong X., O'Donoghue M.B., Tan W. Development of DNA aptamers using Cell-SELEX. Nat Protoc 2010, 5:1169-1185.
13. Wang F.B., Rong Y., Fang M., Yuan J.P., Peng C.W., Liu S.P., et al. Recognition and capture of metastatic hepatocellular carcinoma cells using aptamer-conjugated quantum dots and magnetic particles. Biomaterials 2013, 34:3816-3827.
14. Shangguan D., Li Y., Tang Z., Cao Z.C., Chen H.W., Mallikaratchy P., et al. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A 2006, 103:11838-11843.
15. Iliuk A.B., Hu L., Tao W.A. Aptamer in bioanalytical applications. Anal Chem 2011, 83:4440-4452.
16. Shi H., Tang Z., Kim Y., Nie H., Huang Y.F., He X., et al. Invivo fluorescence imaging of tumors using molecular aptamers generated by cell-SELEX. Chem Asian J 2010, 5:2209-2213.
17. Kanwar J.R., Roy K., Kanwar R.K. Chimeric aptamers in cancer cell-targeted drug delivery. Crit Rev Biochem Mol Biol 2011, 46:459-477.
18. Gao H., Qian J., Yang Z., Pang Z., Xi Z., Cao S., et al. Whole-cell SELEX aptamer-functionalised poly(ethyleneglycol)-poly(ε-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy. Biomaterials 2012, 33:6264-6272.
19. Esposito C.L., Passaro D., Longobardo I., Condorelli G., Marotta P., Affuso A., et al. Aneutralizing RNA aptamer against EGFR causes selective apoptotic cell death. PloS One 2011, 6:e24071.
20. Shangguan D., Tang Z., Mallikaratchy P., Xiao Z., Tan W. Optimization and modifications of aptamers selected from live cancer cell lines. Chembiochem 2007, 8:603-606.
21. Bing T., Yang X., Mei H., Cao Z., Shangguan D. Conservative secondary structure motif of streptavidin-binding aptamers generated by different laboratories. Bioorg Med Chem 2010, 18:1798-1805.
22. Geiger T.R., Peeper D.S. Metastasis mechanisms. Biochim Biophys Acta 2009, 1796:293-308.
23. Zhao N., You J., Zeng Z., Li C., Zu Y. An ultra pH-sensitive and aptamer-equipped nanoscale drug-delivery system for selective killing of tumor cells. Small 2013, 9:3477-3484.
24. Huang Y.F., Shangguan D., Liu H., Phillips J.A., Zhang X., Chen Y., et al. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. Chembiochem 2009, 10:862-868.
25. Xu W., Siddiqui I.A., Nihal M., Pilla S., Rosenthal K., Mukhtar H., et al. Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer. Biomaterials 2013, 34:5244-5253.
26. Minotti G., Menna P., Salvatorelli E., Cairo G., Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 2004, 56:185-229.
27. Zhu G., Meng L., Ye M., Yang L., Sefah K., O'Donoghue M.B., et al. Self-assembled aptamer-based drug carriers for bispecific cytotoxicity to cancer cells. Chem Asian J 2012, 7:1630-1636.
28. Wang T., Ray J. Aptamer-based molecular imaging. Protein Cell 2012, 3:739-754.
29. Hwang do W., Ko H.Y., Lee J.H., Kang H., Ryu S.H., Song I.C., et al. Anucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer. JNucl Med 2010, 51:98-105.
30. Xiao Z., Farokhzad O.C. Aptamer-functionalized nanoparticles for medical applications: challenges and opportunities. ACS Nano 2012, 6:3670-3676.
31. Wang Y., Li Z., Weber T.J., Hu D., Lin C.T., Li J., et al. In situ live cell sensing of multiple nucleotides exploiting DNA/RNA aptamers and graphene oxide nanosheets. Anal Chem 2013, 85:6775-6782.
32. Gao H., Qian J., Cao S., Yang Z., Pang Z., Pan S., et al. Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles. Biomaterials 2012, 33:5115-5123.
33. Larson D.R., Zipfel W.R., Williams R.M., Clark S.W., Bruchez M.P., Wise F.W., et al. Water-soluble quantum dots for multiphoton fluorescence imaging invivo. Science 2003, 300:1434-1436.
34. Liu H., Xu S., He Z., Deng A., Zhu J.J. Supersandwich cytosensor for selective and ultrasensitive detection of cancer cells using aptamer-DNA concatamer-quantum dots probes. Anal Chem 2013, 85:3385-3392.
35. Kang W.J., Chae J.R., Cho Y.L., Lee J.D., Kim S. Multiplex imaging of single tumor cells using quantum-dot-conjugated aptamers. Small 2009, 5:2519-2522.
36. Cao X., Li S., Chen L., Ding H., Xu H., Huang Y., et al. Combining use of a panel of ssDNA aptamers in the detection of Staphylococcus aureus. Nucleic Acids Res 2009, 37:4621-4628.
37. Li N., Ebright J.N., Stovall G.M., Chen X., Nguyen H.H., Singh A., et al. Technical and biological issues relevant to cell typing with aptamers. JProteome Res 2009, 8:2438-2448.